Digital Opinion Leader (DOL)

Key facts

Typical channels

Social media, podcasts, video, blogs and online physician communities

Endorsement disclosure

FTC Endorsement Guides, 16 CFR Part 255, updated in 2023

Sponsored drug content

Can be company promotion subject to FDA advertising and labeling rules

Overlap with KOLs

Partial: many DOLs are also traditional KOLs, many are not

What is a digital opinion leader?

A digital opinion leader is someone whose posts, episodes or videos are read and shared by other clinicians or by patients. Many DOLs are practicing physicians, pharmacists or nurses who comment on new trial data, conference readouts and practice challenges in near real time.

The label emerged as medical conversation moved online and as in-person access to prescribers became harder for field teams. Some DOLs are also traditional key opinion leaders (KOLs) with strong publication records; others have modest academic profiles but large, engaged professional audiences.

Definitions vary between companies. Some limit the term to healthcare professionals, while others include patient advocates and caregivers with large followings.

How DOL influence is measured

There is no standard scoring method. Analysts commonly combine several signals:

Follower counts alone mislead, because a large general audience may include few prescribers in the target specialty.

• Reach: audience size, weighted toward verified healthcare professionals in the relevant specialty.
• Engagement: replies, shares and citations of the content by other clinicians.
• Topic relevance: how often the person discusses a specific disease, drug class or trial.
• Network position: whether other influential experts follow and amplify the person.
• Offline credibility: publications, trial roles and guideline work that support online authority.

Why DOLs matter

Medical and commercial teams track DOLs to understand how new data is received, which concerns about safety or access are spreading, and which voices early adopters listen to. Medical affairs teams may invite DOLs to advisory boards or scientific exchange in the same way they engage KOLs.

Compliance rules apply fully online. When a company pays or supplies an expert to post about its product, the content can be treated as company promotion and must be truthful, non-misleading, fairly balanced and consistent with the approved labeling. The Federal Trade Commission (FTC) Endorsement Guides require clear disclosure of material connections such as payment or free products. Companies should not prompt or amplify off-label discussion, and payments to physicians remain reportable to CMS Open Payments.